Stevens Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Stevens Capital Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,082	Closed	-$90K	–	1170
2016 Q1	$90K	Buy	17,082 +5,263	+45%	+$32.2K	﹤0.01%	829
2015 Q4	$93K	Sell	11,819 -19,220	-62%	-$165K	﹤0.01%	858
2015 Q3	$262K	Buy	31,039 +14,283	+85%	+$132K	0.01%	744
2015 Q2	$183K	Buy	+16,756	New	+$215K	0.01%	890
2015 Q1	–	Sell	-20,502	Closed	-$346K	–	1301
2014 Q4	$346K	Buy	+20,502	New	+$299K	0.01%	673
2014 Q2	–	Sell	-13,841	Closed	-$165K	–	1370
2014 Q1	$165K	Sell	13,841 -4,503	-25%	-$60.4K	﹤0.01%	954
2013 Q4	$253K	Buy	+18,344	New	+$259K	0.01%	847

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stevens Capital Management's INFI Position: Q2 2016 in Review

Stevens Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 17,082 shares — an estimated $90K sold.

Stevens Capital Management first reported a position in INFI in Q4 2013 and held it in 7 quarters. The position peaked at $346K in Q4 2014. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

Stevens Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Stevens Capital Management sold 17,082 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $90K.
Stevens Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 7 quarters.
Stevens Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $346K in Q4 2014.
107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on Stevens Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.